Protein kinase Cγ antibodies and paraneoplastic cerebellar degeneration

J Neuroimmunol. 2013 Mar 15;256(1-2):91-3. doi: 10.1016/j.jneuroim.2012.12.002. Epub 2012 Dec 25.

Abstract

Onconeural antibodies are diagnostic markers for paraneoplastic neurological syndromes and indicate the underlying tumor type. Recently, a new antibody against protein-kinase Cγ (PKCγ) was detected in a patient with paraneoplastic cerebellar degeneration (PCD). We report here a second patient. A 70-year-old woman presented with cerebellar ataxia, dysdiadochokinesia, and dysarthria. Her serum showed immunoreactivity against the cytoplasm, dendrites and axons of Purkinje cells in tissue-based screening, later confirmed by immunoblot and phage plaques as anti-PKCγ. Tumor search revealed an adenocarcinoma of hepatobiliary origin. Detection of PKCγ antibodies should be considered in PCD and adenocarcinoma without typical onconeural antibodies.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Animals
  • Antibodies / blood*
  • Female
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Humans
  • Keratin-20 / metabolism
  • Paraneoplastic Cerebellar Degeneration / blood*
  • Paraneoplastic Cerebellar Degeneration / immunology
  • Paraneoplastic Cerebellar Degeneration / pathology
  • Protein Kinase C / immunology*
  • Purkinje Cells / metabolism
  • Rats

Substances

  • Antibodies
  • Keratin-20
  • protein kinase C gamma
  • Protein Kinase C